FI934387A0 - 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION - Google Patents
3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITIONInfo
- Publication number
- FI934387A0 FI934387A0 FI934387A FI934387A FI934387A0 FI 934387 A0 FI934387 A0 FI 934387A0 FI 934387 A FI934387 A FI 934387A FI 934387 A FI934387 A FI 934387A FI 934387 A0 FI934387 A0 FI 934387A0
- Authority
- FI
- Finland
- Prior art keywords
- carboxiamide
- oxi
- indol
- substitutes
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95793092A | 1992-10-07 | 1992-10-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI934387A0 true FI934387A0 (en) | 1993-10-06 |
FI934387A FI934387A (en) | 1994-04-08 |
Family
ID=25500362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI934387A FI934387A (en) | 1992-10-07 | 1993-10-06 | 3-Substituted 2-oxyindole-1-carboxyamide is a pharmaceutical composition |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0662831A1 (en) |
JP (1) | JP2721042B2 (en) |
KR (1) | KR950703338A (en) |
CN (1) | CN1089138A (en) |
AU (1) | AU676200B2 (en) |
BR (1) | BR9307182A (en) |
CA (1) | CA2146448A1 (en) |
CZ (1) | CZ282702B6 (en) |
EG (1) | EG20289A (en) |
FI (1) | FI934387A (en) |
HU (1) | HUT68533A (en) |
IL (1) | IL107122A (en) |
MX (1) | MX9306222A (en) |
MY (1) | MY109680A (en) |
NO (1) | NO951350L (en) |
NZ (1) | NZ256164A (en) |
PL (1) | PL174170B1 (en) |
RU (1) | RU2119353C1 (en) |
TW (1) | TW438798B (en) |
WO (1) | WO1994007488A1 (en) |
ZA (1) | ZA937405B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2076106B1 (en) * | 1993-08-26 | 1996-06-16 | Pfizer | PHARMACEUTICAL COMPOSITIONS BASED ON 2-OXINDOL-1-CARBOXAMIDES 3-SUBSTITUTED |
AU2517095A (en) * | 1994-05-19 | 1995-12-18 | R.P. Scherer International Corporation | Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions |
JPH10506635A (en) * | 1995-04-24 | 1998-06-30 | ファイザー・インコーポレーテッド | Inhibition of photolysis of 3-substituted-2-oxindole |
WO1998029136A1 (en) * | 1996-12-27 | 1998-07-09 | Takeda Chemical Industries, Ltd. | Stabilized tricyclic compound |
JP5869764B2 (en) * | 2011-01-07 | 2016-02-24 | 中日本カプセル 株式会社 | Capsule filling composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
US5008283A (en) * | 1990-03-19 | 1991-04-16 | Pfizer Inc. | Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
CA2117351C (en) * | 1992-01-13 | 1998-03-03 | Julian Belknap Lo | Preparation of tablets of increased strength |
-
1993
- 1993-08-17 TW TW082106612A patent/TW438798B/en active
- 1993-09-02 PL PL93308307A patent/PL174170B1/en unknown
- 1993-09-02 RU RU95111378A patent/RU2119353C1/en active
- 1993-09-02 CZ CZ95878A patent/CZ282702B6/en unknown
- 1993-09-02 NZ NZ256164A patent/NZ256164A/en unknown
- 1993-09-02 KR KR1019950701320A patent/KR950703338A/en not_active Application Discontinuation
- 1993-09-02 CA CA002146448A patent/CA2146448A1/en not_active Abandoned
- 1993-09-02 WO PCT/US1993/008063 patent/WO1994007488A1/en not_active Application Discontinuation
- 1993-09-02 JP JP6509043A patent/JP2721042B2/en not_active Expired - Lifetime
- 1993-09-02 BR BR9307182A patent/BR9307182A/en not_active Application Discontinuation
- 1993-09-02 AU AU48392/93A patent/AU676200B2/en not_active Ceased
- 1993-09-02 EP EP93921210A patent/EP0662831A1/en not_active Withdrawn
- 1993-09-27 IL IL10712293A patent/IL107122A/en not_active IP Right Cessation
- 1993-10-04 EG EG64393A patent/EG20289A/en active
- 1993-10-05 MY MYPI93002026A patent/MY109680A/en unknown
- 1993-10-06 HU HU9302821A patent/HUT68533A/en unknown
- 1993-10-06 MX MX9306222A patent/MX9306222A/en unknown
- 1993-10-06 ZA ZA937405A patent/ZA937405B/en unknown
- 1993-10-06 FI FI934387A patent/FI934387A/en not_active Application Discontinuation
- 1993-10-06 CN CN93118904A patent/CN1089138A/en active Pending
-
1995
- 1995-04-06 NO NO951350A patent/NO951350L/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR950703338A (en) | 1995-09-20 |
PL174170B1 (en) | 1998-06-30 |
PL308307A1 (en) | 1995-07-24 |
HUT68533A (en) | 1995-04-27 |
JPH07507809A (en) | 1995-08-31 |
RU2119353C1 (en) | 1998-09-27 |
EP0662831A1 (en) | 1995-07-19 |
NZ256164A (en) | 1997-03-24 |
CZ87895A3 (en) | 1995-10-18 |
MX9306222A (en) | 1994-04-29 |
JP2721042B2 (en) | 1998-03-04 |
ZA937405B (en) | 1995-04-06 |
CZ282702B6 (en) | 1997-09-17 |
IL107122A0 (en) | 1993-12-28 |
NO951350L (en) | 1995-06-06 |
TW438798B (en) | 2001-06-07 |
EG20289A (en) | 1998-07-30 |
AU676200B2 (en) | 1997-03-06 |
WO1994007488A1 (en) | 1994-04-14 |
IL107122A (en) | 1998-08-16 |
HU9302821D0 (en) | 1993-12-28 |
AU4839293A (en) | 1994-04-26 |
CN1089138A (en) | 1994-07-13 |
FI934387A (en) | 1994-04-08 |
MY109680A (en) | 1997-04-30 |
NO951350D0 (en) | 1995-04-06 |
BR9307182A (en) | 1999-03-30 |
CA2146448A1 (en) | 1994-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE03108B1 (en) | Pharmaceutical composition | |
FI981777A0 (en) | Pharmaceutical composition | |
PT589843E (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS | |
FI944832A0 (en) | Pharmaceutical composition | |
BR1100824A (en) | Pharmaceutical composition and composition | |
DE69325158D1 (en) | Photocromic composition | |
FI930882A (en) | PHARMACEUTICAL FORM | |
NO923127L (en) | PHARMACEUTICAL COMBINATION FORM | |
NO931831D0 (en) | PHARMACEUTICAL MIXTURES | |
BR9200058A (en) | PHARMACEUTICAL COMPOUND AND COMPOSITION | |
MX9200622A (en) | PHARMACEUTICAL COMPOSITION | |
ITMI932540A0 (en) | PHARMACEUTICAL COMPOSITION | |
DE4294862T1 (en) | Pharmaceutical composition | |
NO934145D0 (en) | Pharmaceutical compounds | |
FI931251A (en) | PHARMACEUTICAL FORM | |
BR9507768A (en) | Pharmaceutical composition | |
UA26064A1 (en) | PHARMACEUTICAL COMPOSITION | |
LV10579A (en) | Pharmaceutical composition | |
FI934387A0 (en) | 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION | |
DE69217904D1 (en) | composition | |
FI952377A0 (en) | Pharmaceutical ibuprofen compositions | |
IT1272935B (en) | PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN | |
SE9202820D0 (en) | PHARMACEUTICAL COMPOSITION | |
ITMI922581A0 (en) | PHARMACEUTICAL COMPOSITION | |
ITMI922580A1 (en) | PHARMACEUTICAL COMPOSITION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |